Changes in structure, cellularity, hematopoietic progenitor cell and macrophage content, and osteoclast activity were investigated in the hematopoietic organs of the colony-stimulating factor l(CSF-1)-less osteopetrotic (op/op) mouse. The data indicated that op/op mice undergo an agerelated hematopoietic recovery and resolution of osteopetrosis, suggesting that the hematopoietic system has the capacity to use alternative mechanisms to compensate for the absence of an important multifunctional growth factor, CSF-1. In young animals, op/op femurs were heavily infiltrated with bone, and marrow cellularity was significantly reduced. After 6 wk of age, there was an increase in the marrow space available for hematopoiesis. The femoral cavity of op/op mice progressively enlarged, and by 22 wk of age its appearance and marrow cellularity was comparable to that of controls. The percentage of op/op mononuclear phagocytes, defined by F4/80 antigen expression, progressively increased to normal levels by 35 wk of age. There was no difference in the incidence of both primitive and mononuclear phagocyte-committed, CSF-l-responsive progenitor cells in op/op marrow, but their femoral content was significantly reduced in young mice. During the period of reduced hematopoiesis in the marrow of young op/op mice, splenic hematopoietic activity was devated. This mutant mouse represents a system for the study of the CSF-l-independent regulatory mechanisms involved in hematopoietic regulation.
C
SF-1 stimulates the survival, proliferation, and differentiation of mononuclear phagocytes and their precursors (1) (2) (3) . Osteopetrotic (op/op) mice are characterized by an antosomal recessive inactivating mutation in the CSF-1 gene resulting in the absence of CSF-1 (4-7). As a consequence, young op/op mice have impaired mononuclear phagocyte development (1, 2) characterized by a deficiency of both macrophages and osteodasts. Bone density is increased, marrow cavities are occluded (8) (9) (10) (11) , and it has been reported that marrow cellularity of op/op mice is 10%, and marrow macrophage content is 1%, that of control mice (12) .
Previous studies have generally been restricted to analysis of young op/op mice (6, 7, 9, 12, 13) . In these mice, bone matrix formation is elevated, but by 6 wk of age there is evidence of remodeling in the long bones (8, 10) . This raises the possibility that in older op/op mice there are significant changes in the organization and regulation of hematopoiesis associated with a substantial correction of the osteopetrosis. In the present study, hematopoietic and mononuclear phagocyte development was investigated in op/op mice from 2 wk to 5 mo of age. Progressive changes in the structure of the femoral marrow space were accompanied by a normalization of marrow cellularity and macrophage content, demonstrating that as op/op mice age they correct hematopoietic deficiencies in the absence of CSF-1.
Materials and Methods
Mice. Mice ofop/op and wild-type control (+/+, op/+ ) genotypes were raised as previously described (14) . Osteopetrotic (op/op) mice were distinguished from normal siblings at 10 d of age by the absence incisor eruption, and separated from wild-type mice at weaning. They were fed a pureed mixture of mouse food (Barastoc, St. Arnaud, Victoria, Australia) and infant formula (Ensure; Ross Laboratories, Columbus, OH) twice daily to optimize their nutritional status. Control mice received mouse chow ad libitum.
Growth Factors. Human rCSF-1 (8 x 107 U/rag protein) was a gift from Chiron Corp. (EmeryviUe, CA). Human rIL-lc~ (2.5 x 109 U/rag protein) was a gift from Hoffman-La Roche Inc.
(Nutley, NJ). rlL-3 was prepared as conditioned medium from the genetically altered mouse mammary cell line (C127) expressing mouse cDNA (15) . Factors were used at optimal concentrations (16) .
Preparation of Microscopic Sections. Anesthetized (Penthrane; Abbott Laboratories, North Chicago, IL) mice were perfused with 4 ml of 2.5% ghtaraldehyde at 0.3 ml/min into the descending aorta (17) . Femurs were immersion fixed for a further 3 h before decalcification in 10% EDTA (pH 7.0) for 5-7 d. Postfixation with 2% osmium tetroxide (80 mM Sorensen's phosphate buffer, pH 7.4) for 1 h was followed by dehydration in graded ethanol, and 100% acetone for 45 min at each step in a vacuum. Femurs were placed in a 1:1 mixture of Spurr's resin and 100% acetone in a vacuum overnight, then for 6 h in fresh solution. The femurs were embedded in 100% Spurr's resin in a vacuum for 3 h followed by incubation at 60~ overnight. For light microscopy, 0.5 #m transverse sections were cut and stained with methylene blue. For EM, 0.9-nm sections were cut and stained using uranyl acetate and lead citrate.
Cells Suspensions. Marrow from control mice was collected by flushing femoral shafts with cold Hepes-bui[ered balanced salt solution (BSS) supplemented with 2% newborn bovine serum (NBBS). Femurs from op/op mice were routinely ground using a mortar and pestle because <20% of marrow cells could be recovered by flushing alone. The suspension was gently vortexed to free ceUs adhering to bone fragments, and the supematant decanted and pooled, together with three washings of the bone fragments. Spleen cell suspensions were prepared by mincing in BSS supplemented with 2% NBBS, and dispersed through a mesh sieve. Cell counts were performed using a hemocytometer.
Hematot, oietic Progenitor CelIAssa?s. Marrow and spleen cell suspensions were assayed for low and high proliferative potential colonyforming cells (LPP-CFC and HPP-CFC), using a double-layer nutrient agar culture system (16) .
Flow Cytometric Analysis. Bone marrow macrophage content
was quantitated on the basis of F4/80 cell surface Ag expression (18) . Ceils were labeled with F4/80 Ab, followed by FITCconjugated goat anti-rat F(ab')z IgG (Kirkegaard & Perry Laboratories, Inc., Gaitbersburg, MD); each for 30 min at 4~ and were analyzed using a FACStar Plus | cell sorter (Becton Dickinson & Co., Mountain View, CA). A forward vs. perpendicular light scatter window was set to exclude lymphocytic and granulocytic cells that may be nonspecifically labded with F4/80 Ab (19) . Background fluorescence (cell surface binding of FITC-conjugated second Ab) was not >5%.
Osteoclast Staining. Mice were anesthetized and perfused with 2 ml of 1% glutaraldebyde and 1% formaldehyde into the descending aorta. Femurs were immersion fixed at 4~ for 1 h before decalcification in 5% EDTA in cacodylate buffer at 4~ for 5 d. The femurs were dehydrated in graded ethanol and xylene for 90 min at each step and embedded in paraplast. Sections (10 #m) were cut and stained using tartrate-resistant ATPase histocbemistry.
Resorption Pit Anal?sis. Femurs were eafised using blunt dissection. After immersion fixation in 2.5% glutaraldehyde overnight at 4~ and 8 h in a vacuum, they were placed in 4% (wt/vol) NaOC1 to remove remaining tissue. Femurs were dehydrated in graded ethanol for 125 rain in a vacuum, and, after critical point drying, were sputter coated with 30 ~m of gold and examined by scanning electron microscopy.
Statistical Analysis. Differences between means were evaluated by one-way analysis of variance (ANOVA). lularity in young op/op mice reflected occlusion of the marrow space by bone: there was no obvious central marrow cavity at 4 wk of age (Fig. 2 A) . By 6 wk of age, formation of a central marrow cavity resulted in an increase in the space available for hematopoiesis (Fig. 2 , B and C). Thereafter, the
Results

Changes in Bone Structure, Marrow Cellularity, and Heraatopoietic Activity of op/op Mice
The femoral marrow cellularity of control mice progressively increased postnatally, attaining adult levels by 6-8 wk of age. In contrast, op/op marrow cdlularity remained stable at ,,02.5 x 106 cells per femur during this period, and by 8 wk had only attained 16% of the cellularity of control femurs (Fig. 1) . This decreased cd- marrow cavity progressively enlarged, and by 22 wk of age (Fig. 2 D) , its appearance was comparable to that of control mice (Fig. 2, E and F) . However, the femurs of op/op mice remained shorter and more stunted than those of control mice at all ages examined.
k-
The increase in marrow space in op/op femurs was accom--~ panied by an increase in cellularity, which also became com-IF so parable to that of control femurs by 22 wk of age (Fig. 1) .
,.~ This progressive increase in space available for hematopoiesis ~ 4o was indicative of increased osteoclast activity. Very few os-~ ~o teoclasts were observed along the edge of the marrow cavity op/op mice (Fig. 3 C) . As well, the rugged irregular edges of the femoral surface were suggestive of bone formation (Fig.   3 C) . However, by 22 wk of age, the femoral surface of op/op mice resembled that of control mice, with resorptive pits being clearly distinguishable (Fig. 3, E-H) .
Flow cytometric analysis of F4/80 surface Ag expression on mononuclear cells with defined light scattering properties (see Materials and Methods) demonstrated an age-related correction of the marrow macrophage deficiency observed in young op/op mice. At 3 wk of age the proportion of F4/80 + cells was '~50% that in control marrow (Table 1) . By 35 wk of age the proportion and number of F4/80 + cells in the op/op mouse was comparable to that of controls ( Table  1) . The presence of macrophages in op/op marrow was confirmed by electron microscopy. No morphological differences were observed between macrophages detected in op/op and control mice at any age examined, and paracrystaUine inclusions (20) were present in macrophages of normal and op/op mice of comparable age (data not shown). vivo (21) . There were no differences in the incidence of LPP-CFC or HPP-CFC in the marrow of op/op and control mice at any age examined (data not shown). However, the total femoral content of these progenitors (Fig. 4) reflected the agerelated changes observed in marrow cellularity (Fig. 1) . LPP-CFC and HPP-CFC levels in 6-wk-old op/op mice were ",,10-fold less than that of control mice. By 22 wk of age, the femoral progenitor cell content in op/op and control mice was comparable (Fig. 4) . The diminished space for marrow hematopoiesis and the reduced hematopoietic activity in young op/op mice were correlated with an increase in splenic hematopoiesis. At 6 wk of age, the spleens ofop/op mice were significantly enlarged, and the incidence and content of both LPP-CFC and HPP-CFC were significantly higher than those of control mice (Table 2 , Fig. 5 ). By 27 wk of age, at a time when op/op marrow cellularity had normalized (Fig. 1) , the incidence and content of progenitor cells in the spleen had declined to values equivalent to those in control mice (Table 3 Age (wk) 
Changes in Heraatopoietic Progenitor Cell Populations in op/op
Discussion
Previous studies of op/op mice, which are largely restricted to the biology of macrophages and osteodasts in young mice, indicate that occlusion of the marrow cavity by bone is associated with a severe decrease in cellularity, and a deficiency of osteodasts and mononuchar phagocytes (11, 12, (22) (23) (24) (25) (26) . These findings were confirmed, however, it appears that the decrease in marrow cellularity is less severe than pmriously reported, and the osteopetrosis and hematopoiesis deficiencies in op/op mice are not permanent. In contrast to previous studies of op/op mice up to 4 mo of age, indicating no increase in marrow cellularity or frequency of F4/80 + cells (25, 27) , the present study showed a progressive age-related increase in marrow cellularity and macrophage content. This increase in cellularity was apparent by 8 wk, and continued until normal levds were reached by 22 wk. By 35 wk of age the frequency and total number of F4/80 + cells was also normal.
The normalization of marrow cellularity in op/op mice was associated with remodeling of the marrow cavity, reduction of bone matrix formation, and the appearance of resorptive pits on the femoral surface. During this period, there was a slow resolution of the osteopetrosis with the formation of a marrow space comparable to that seen in control mice. In agreement with our data, other workers (8, 10, 26) have also noted evidence of the beginnings of the formation of a femoral shaft in 6-wk-old op/op mice.
Variations in the data from different laboratories appear to be due to differences in bone sampling methodology and nutritional status of the mice. As to the latter, we have noticed that the combination of an enriched diet and early separation of op/op mice from their normal littermates greatly improves the rate of hematopoietic recovery.
Although there were comparable proportions of HPP-CFC and LPP-CFC in the marrow of young op/op and control mice, the absolute number of these progenitors was reduced. The normal frequency of LPP-CFC in op/op marrow from young mice was unexpected, since in vitro it has been shown that generation of LPP-CFC from HPP-CFC is CSF-1 dependent (16, 28) . In op/op mice it is possible that both the rate of generation of LPP-CFC as well as their CSF-l-induced differentiation are slowed, resulting in the same concentration of LPP-CFC as in normal mice. Alternatively, the normal concentration of LPP-CFC (and HPP-CFC) could be due to the presence of a growth factor with a CSF-l-like effect.
Interestingly, during the period of suppressed marrow hematopoiesis in young op/op mice, there was an increase in splenic hematopoiesis and cellularity. Splenic granulocytopoiesis and megakaryocytopoiesis was elevated (data not shown), as well as the frequency and number of LPP-CFC and HPP-CFC. Other studies have indicated that daily administration of CSF-1 to newborn op/op mice is required to prevent osteopetrosis and accompanying hematopoietic defidencies (29) .
However, our data suggest that the hematopoietic system has the capacity to use alternative mechanisms to compensate for 
